2011
DOI: 10.1002/14651858.cd009523
|View full text |Cite
|
Sign up to set email alerts
|

Selective vasopressin type 2 receptor antagonist for patients with cirrhosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2015
2015
2021
2021

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 19 publications
0
2
0
Order By: Relevance
“…In a Cochrane review, Chavez‐Tapia et al (21) concluded that the lack of randomized clinical trials or quasirandomized clinical studies prevents definitive assessment of benefits and harms of bariatric surgery as a therapeutic approach for patients with NASH. In fact, there are a small number of retrospective and prospective cohort studies that compare liver histology in severely obese individuals before and after bariatric surgery.…”
Section: Clinical Indicationsmentioning
confidence: 99%
“…In a Cochrane review, Chavez‐Tapia et al (21) concluded that the lack of randomized clinical trials or quasirandomized clinical studies prevents definitive assessment of benefits and harms of bariatric surgery as a therapeutic approach for patients with NASH. In fact, there are a small number of retrospective and prospective cohort studies that compare liver histology in severely obese individuals before and after bariatric surgery.…”
Section: Clinical Indicationsmentioning
confidence: 99%
“…Although adhering to and monitoring compliance with preprocedure protocols are likely sensible means of mitigating procedural risks (34), particularly infection, bleeding and sedation, there are limited data for this and few pediatric‐specific studies. In terms of antibiotic prophylaxis, a Cochrane systematic review concluded that its use in adults with cirrhosis and upper gastrointestinal bleeding was beneficial (35). Another Cochrane systematic review found a significant reduction in the incidence of peristomal infection with prophylactic antibiotics after percutaneous endoscopic gastrostomy placement in adults (36).…”
Section: Resultsmentioning
confidence: 99%